Remarks: TAK-700 is a type of selective effect of oral non-steroidal androgen synthesis inhibitors. Pre-clinical results show that it can selectively lock and inhibit the testes and adrenal glands among the 17, 20 carbon chain cleavage enzyme
None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer.